← Product Code LOS · K981066

# FUKUDA DENSHI: CARDIOMAX, MODEL FX-4010 MULTI CHANNEL ELECTROCARDIOGRAPH (K981066)

_Fukuda Denshi USA, Inc. · LOS · Aug 31, 1998 · CV · SESE_

**Canonical URL:** https://fda.innolitics.com/device/K981066

## Device Facts

- **Applicant:** Fukuda Denshi USA, Inc.
- **Product Code:** LOS
- **Decision Date:** Aug 31, 1998
- **Decision:** SESE
- **Submission Type:** Traditional
- **Review Panel:** CV
- **Attributes:** Pediatric

## Intended Use

This Fukuda Denshi model FX-4010 Multi Channel Electrocardiograph is intended to be used for the evaluation of the cardiovascular system. The FX-4010 will acquire and record ECG waveforms. Also, the FX-4010 can provide ECG interpretation. The FX-4010 is to be used by or on the order of a physician or similarly qualified health care professional. The FX-4010 may be used in all hospital environments; ER, OR, ICU, etc .; doctors' offices; clinics; or similar settings. This device is intended to be used on any patient; neonate, pediatric, or adult; where the placement of EKG electrodes does not interfere with or complicate the treatment of the patient. The interpretive feature is to be used on any patient, at least one (1) year old, where the placement of EKG electrodes does not interfere with of complicate the treatment of the patient. This device is not intended for home use.

## Device Story

Portable, multi-channel, interpretive electrocardiograph; acquires and records electrical heart signals via surface electrodes; produces thermal printouts. Used in hospitals (ER, OR, ICU), clinics, and doctors' offices by physicians or qualified professionals. Features include ECG waveform recording, interpretive analysis, R-to-R timing measurements, and arrhythmia interpretation. Provides diagnostic data to assist clinicians in patient management. Includes 2MB memory card port and accessory cartridges. Not for home use.

## Clinical Evidence

Bench testing only. Validated against design specifications and predicate device (FCP-2155). Testing included environmental stress, electrical safety (ANSI/AAMI ES1-1993), and diagnostic performance (ANSI/AAMI EC11-1991). Hazard analysis and software validation performed to ensure operational safety.

## Technological Characteristics

Portable unit (37.8x33.8x10.1 cm, 8 kg). Microprocessor-controlled; thermal printer; LCD display; 2MB memory card port; accessory cartridges/modules. Rechargeable battery. Electrical safety per UL 2601, CSA 22.2, and AAMI standards. Software-controlled interpretive analysis.

## Predicate Devices

- Fukuda Denshi FCP-2155, Multi Channel Interpretative ECG ([K971440](/device/K971440.md))

## Submission Summary (Full Text)

> This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com.
>
> Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/).

{0}------------------------------------------------

K981066

AUG 3 1 1998

# Section 2 510(k) Summary Fukuda Denshi model FX-4010

Multi Channel Electrocardiograph

This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR part 807.92.

K981066 The assigned 510(k) number is:

### Submitter:

FUKUDA DENSHI AMERICA CORP. 17725 NE 65th St. Bldg C Redmond, WA 98052-4911 Tel: 425/881-7737 425/869-2018 Fax:

#### Contact Person:

Richard A. Queen Regulatory Affairs Specialist FUKUDA DENSHI AMERICA CORP. 17725 NE 65th St. Bldg C Redmond, WA 98052-4911 425/881-7737 Tel: Fax: 425/869-2018

Date Prepared:

March 10, 1998

### Device Name:

Proprietary Name:

Fukuda Denshi: CardioMax, model FX-4010 Multi Channel Electrocardiograph

#### Common Name:

Multi Channel Interpretive Electrocardiograph

#### Classification Name:

Electrocardiograph

### Legally Marketed Device:

FCP-2155, Multi Channel Interpretative ECG (K971440)

FX4010 Reve Additional Information 40102a

{1}------------------------------------------------

### Description:

The Fukuda Denshi model FX-4010 Multi Channel Electrocardiograph is a portable, multi channel, interpretive, automatic or manual electrocardiograph. This electrocardiograph is designed to produce a thermally printed recording of the electrical signals produced by the heart. The size of the unit is 37.8(W) x 33.8(D) x 10.1(H) cm and weighs approximately 8 kg.

# Intended Use:

This Fukuda Denshi model FX-4010 Multi Channel Electrocardiograph is intended to be used for the evaluation of the cardiovascular system. The FX-4010 will acquire and record ECG waveforms. Also, the FX-4010 can provide ECG interpretation. The FX-4010 is to be used by or on the order of a physician or similarly qualified health care professional. The FX-4010 may be used in all hospital environments; ER, OR, ICU, etc .; doctors' offices; clinics; or similar settings. This device is intended to be used on any patient; neonate, pediatric, or adult; where the placement of EKG electrodes does not interfere with or complicate the treatment of the patient.

The interpretive feature is to be used on any patient, at least one (1) year old, where the placement of EKG electrodes does not interfere with of complicate the treatment of the patient. This device is not intended for home use.

### Technological Characteristics

The Fukuda Denshi model FX-4010 Multi Channel Electrocardiograph incorporates the microprocessor, thermal printer, input and output channels, measurement and interpretive analysis, and LCD technology similar to the predicate device. The FX-4010 has a port for plugging in a 2-megabyte memory card for storing data. Also, the 4010 has the ability to have accessory cartridges and modules to enables its basic ECG functions. A rechargeable battery is available on both devices.

These technological differences do not affect the safety or efficacy of the device. Any safety issues that may be raised by a software controlled medical device are addressed in the system's hazard analysis and the system validation.

{2}------------------------------------------------

Testing:

Laboratory testing was conducted to validate and verify the Fukuda Denshi model FX-4010 Multi Channel Electrocardiograph met all design specifications and was substantially equivalent to the FUKUDA DENSHI model FCP-2155. This testing consisted of all environmental testing identified in the FDA's DCRND November 1993 "Reviewer Guidance Document for Premarket notification Submissions" Draft Guidance Document. Additional testing was performed to demonstrate compliance with ANSI/AAMI ES1-1993, "Safe current limits for electromedical apparatus," ANSI/AAMI EC11-1991, "Diagnostic Electrocardiographic Devices". Finally, a hazard analysis of the system and its software was performed and testing was conducted to validate the systems overall operation.

Although the device is neither life supporting nor life sustaining, diagnostic information derived from the use of the device may be critical to the proper management of the patient.

So, the areas of risk for this device are the same as the predicate device and other devices in this class, and are the following:

- . Electrical shock
Excessive electrical chassis leakage current can disturb the normal electrophysiology of the heart, and possibly leading to the onset of cardiac arrhythmias.

- Misdiagnosis .
	- Inadequate design of the signal processing and measurement circuitry or program can lead to generation of inaccurate diagnostic data. If inaccurate diagnostic data are used in managing the patient, the physician may prescribe a course of treatment that places the patient at risk unnecessarily.
	- Inadequate design of the device's software, used to make various measurements, can lead to generation of inaccurate diagnostic data. If inaccurate diagnostic data are used in managing the patient, the physician may prescribe a course of treatment that places the patient at risk unnecessarily.

The design of the FX-4010 has taken into account all the above. The device is designed to meet UL 2601, CSA 22.2 and AAMI standards for electrical safety for medical equipment to prevent the possibility of excessive electrical leakage current to the patient.

{3}------------------------------------------------

## Conclusion:

The conclusions drawn from clinical and laboratory testing of Fukuda Denshi model FX-4010 Multi Channel Electrocardiograph demonstrates that the device is as safe, as effective, and performs as well as or better than the legally marketed predicate device, the Fukuda Denshi model FCP-2155 Multi Channel Electrocardiograph (K971440).

FX4010 Reve Additional Information 40102a

:

{4}------------------------------------------------

Image /page/4/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized symbol that resembles a human figure in profile, with three overlapping heads and flowing lines representing the body.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

AUG 31 1998

Mr. Richard Queen Fukuda Denshi America Corporation 17725 NE 65th Street Redmond, WA 98052

K981066 Re: Fukuda Denshi CardioMax Model FX-4010, Multi Channel Electrocardiograph Requlatory Class: III (three) Product Code: 74 LOS Dated: July 8, 1998 Received: July 15, 1998

Dear Mr. Queen:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Requlation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or requlations.

{5}------------------------------------------------

#### Page 2 -- Mr. Richard Queen

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4648. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification"(21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597, or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".

Sincerely yours,

Thomas J. Callahon

Thomas J. Chllahan, Ph.D. Director Division of Cardiovascular, Respiratory, and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{6}------------------------------------------------

# Indications for Use Statement

510(k) Number (if known):

K981066

| Device Name:         | Fukuda Denshi: CardioMax, model FX-4010,<br>Multi Channel Electrocardiograph                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|----------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications For Use: | Use of this device is indicated where a physician or healthcare<br>professional requires information about the electrical events within<br>the myocardium using waveforms recorded from the body's<br>surface during depolarization and repolarization of the atrium and<br>ventricles. The FX-4010 is indicated where a clinician seeks<br>advisory interpretive measurement, and diagnostic statements that<br>would require confirmation by a physician. Also, can provide<br>measurement data, R to R timing measurements with trend<br>information and interpretation of arrhythmia to the clinician. |
| Indications For Use: | The basic EKG and recording features of this device are intended<br>to be used on any patient; neonate, pediatric, or adult; where the<br>placement of EKG electrodes does not interfere with or complicate<br>the treatment of the patient. The interpretive feature of this device<br>is intended to be used on any patient, at least one (1) year old,<br>where the placement of EKG electrodes does not interfere with or<br>complicate the treatment of the patient. This device is not intended<br>for home use.                                                                                     |

#### (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED

Concurrence of CDRH, Office of Device Evaluation (ODE)

Kramer

(Division Sign-Off) Division of Cardiovascular, Respiratory, and Neurological Devices K981066 510(k) Number_

Prescription Use (Per 21 CRF 801.109)

Over-The-Counter Use _________________________________________________________________________________________________________________________________________________________

---

**Source:** [https://fda.innolitics.com/device/K981066](https://fda.innolitics.com/device/K981066)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com